The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

Few companies garner as much reliable attention as Novo Nordisk (NYSE: NVO) does these days. With a bull market coinciding with a historic run of growth for the Danish pharmaceutical giant related ...

Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as US President Joe Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid. “This is an ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other profitable European stocks. After the U.S. Presidential elections, the global economies ...

Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply injection pens for Danish drugmaker’s next-gen obesity therapy ...

LONDON (Reuters) – Swiss medical technology company Ypsomed’s contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker’s next-generation experimental obesity drug ...

Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology company Ypsomed could include the supply of injection pens for CagriSema, the former’s ...

Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology company Ypsomed could include the supply of injection pens for CagriSema ... an automated ...